The Association
The association for Cancer Immunotherapy (CIMT) is a non profit organisation and was founded in fall 2002 as an information and education platform for immunological cancer therapy. Physicians and researchers from different fields of clinical and theoretical medicine from the universities of Berlin, Erlangen, Mainz and Tübingen are the founders of the association.CIMT is located at the university medical center of the Johannes Gutenberg University Mainz.
The association is financed by donations, congress fees and sponsoring.
Our Goals
The purpose of CIMT is enhancing the development of cancer immunotherapies by:- Establishing a communication platform in order to facilitate the communication between scientists of all faculties with interest in cancer immunotherapy. We improve knowledge exchange between industry based scientists, academic scientists, regulatory authorities and physicians alike. Our scientific meetings, educational symposia and publications serve this purpose.
- Education of health-professionals with annual meetings, advanced education seminars and publication of text-books.
- Cooperation with partners in related consortia, regulatory agencies, journals, academic institutions and companies.
- Initiation of working parties that actively accelerate the development in the field.
